The Efficacy and Safety of Sandbag Self Walking-MSAT on Acute Low Back Pain
1 other identifier
interventional
104
1 country
1
Brief Summary
This study is a double blind, randomized controlled trail. condition/disease: acute low back pain treatment/intervention: motion style acupuncture treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Jul 2021
Typical duration for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2021
CompletedFirst Submitted
Initial submission to the registry
August 5, 2022
CompletedFirst Posted
Study publicly available on registry
August 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2022
CompletedOctober 10, 2023
October 1, 2023
1.2 years
August 5, 2022
October 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale(NRS) of Low back pain
The extent of Low back pain and discomfort will be assessed using NRS. NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their low back pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.
Change from baseline NRS at 4 days
Secondary Outcomes (11)
Visual Analogue Scale (VAS) of Low back pain
visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days)
Numeric Rating Scale(NRS) of leg pain
visit1(day1), visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days), visit6(1 month after discharge), visit7(3 months after discharge)
Visual Analogue Scale (VAS) of leg pain
visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days)
Physical examination (Lumbar range of motion)
visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days)
Oswestry Disability Index (ODI)
visit2(day2), day of discharge(up to 14days), visit6(1 month after discharge), visit7(3 months after discharge)
- +6 more secondary outcomes
Study Arms (2)
Sandbag motion style acupuncture treatment
EXPERIMENTALThe MSAT group will recieve 3 sessions of MSAT; on second, third, fourth day after hospitalization. A trained doctor of Korean medicine with at least 3 years of clinical experience will conduct the MSAT. The MSAT group will be also treated with other Korean medical treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Korean medical treatment
ACTIVE COMPARATORThe control group will be received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine
Interventions
Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation.
acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine.
Eligibility Criteria
You may qualify if:
- Patients aged 19-70 years on the date they sign the consent form
- Patients who needs hospitalization due to acute low back pain that occurred within 7 days after traffic accident
- Patients with NRS ≥ 5 for low back pain
- Patients who provide consent to participate in the trial and return the informed consent form
You may not qualify if:
- Patients with a specific serious disease that may cause spinal pain: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients with progressive neurological deficits or with severe neurological symptoms
- Patients who have had surgery or procedures within the last three weeks
- The cause of pain is due to soft tissue disease, not the spine: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
- Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
- Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
- If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease
- Patients who are pregnant or planning to become pregnant
- Patients with a serious mental illness
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement
- Other patients whose participation in the trial is judged by a researcher to be problematic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
In-Hyuk Ha, PhD
Jaseng Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 5, 2022
First Posted
August 9, 2022
Study Start
July 17, 2021
Primary Completion
September 26, 2022
Study Completion
September 26, 2022
Last Updated
October 10, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share